| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MOLECULAR PHARMACOLOGY LetPub Score 7.4
50 ratings
Rate
Reputation 8.7 Influence 6.4 Speed 7.0 | ||||||||||||||||||||
| 期刊簡稱 | MOL PHARMACOL | ||||||||||||||||||||
| ISSN | 0026-895X | ||||||||||||||||||||
| E-ISSN | 1521-0111 | ||||||||||||||||||||
| h-index | 186 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 3.10%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://molpharm.aspetjournals.org/ | ||||||||||||||||||||
| 在線稿件提交 | http://submit-molpharm.aspetjournals.org/ | ||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | American Society for Pharmacology and Experimental Therapeutics | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||||||
| 創刊年 | 1965 | ||||||||||||||||||||
| 每年文章數 | 3每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 19.05% | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q2
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0026-895X%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [MOLECULAR PHARMACOLOGY] 的評論 | 撰寫評論 |
| 作者: 坠星晓慧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-09-01 10:14:55 評論於 Is this magazine easy to get published in? I submitted an article myself, but it hasn't even been sent for review yet, which doesn't bode well. Oh well, there goes 500 bucks, those foreigners are really smart  (0) 讚！ | 坠星晓慧  |
| 作者: Yetta Beerbohm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-01-17 22:17:15 評論於 ** I submitted an article myself, but it hasn't been reviewed yet, which means it's unlikely to be accepted. Oh, I wasted 500 dollars. Foreigners are really clever. ** (0) 讚！ | Yetta Beerbohm |
| 作者: Anonymous 領域: 医药科学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2016-08-23 09:41:19 評論於 The influence factor changes greatly. (0) 讚！ | Anonymous |
| 作者: Primo Aly 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2015-06-09 19:06:07 評論於 Over the past half month, there have been tragedies, the reasons for which are unclear, after all, it is a top-tier magazine, and the requirements for submission are quite rigorous (0) 讚！ | Primo Aly |
| 作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-11-06 12:19:00 評論於 2010, 4.7, very difficult to select, requires pictures to be beautiful, logically clear! (0) 讚！ | 匿名 |
| 作者: 风陵妙夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2011-11-06 08:58:22 評論於 In 2010, April 7th, it was very difficult to pitch, requiring beautiful images and clear logic! (0) 讚！ | 风陵妙夏 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us